Trial Activation: EA5221/ACHIEVE, led by Megan Baumgart, MD of @UR_Med & @DrSteveMartin of @EinsteinMed, is a randomized phase III study of chemo-immunotherapy vs #immunotherapy alone for the vulnerable older adult with advanced non-small cell #lungcancer. https://t.co/4iFs1j4lU7
Meet our team of international experts in the field of #lymphoma. They share updates from congresses, discuss scientific data and create educational resources for HCPs around the world. Find out more: https://t.co/NB2lXArGvP
#lymsm#MedEd
Deeply saddened to hear about the loss of my highly valued life time friend and colleague,Dr Steven Coutre. Being fellows together at Stanford almost 30 years back was a great opportunity to learn from his exceptional manners, fine intellect and highest quality care @StanfordMed
New @TheLancet study led by Wilmot researcher Dr. Supriya Mohile (@rochgerionc) proves geriatric assessment benefits cancer patients age 70+. The results are potentially practice changing. #gerionc#URochesterResearch
https://t.co/1c0CKhmkEJ
Look who's on the cover of the Fall edition of Pulse, a publication of the @lymphoma Research Foundation. Read more about our very own @SoniSmithMD https://t.co/cseOswmxox
The legacy and spirit of the Rochester Rhinos is ingrained in us and it will stay this way forever. However, after a break from the game and a fresh start with our new co-owner, we have the opportunity to re-launch and reposition ourselves as a global brand in football #RNYFC